About ramipril
NHS medicines information on ramipril – what it's used for and key facts.
www.nhs.ukHere’s the latest high-level update on ramipril, with emphasis on recalls and safety notices.
What ramipril is
- Ramipril is an ACE inhibitor used to treat high blood pressure, heart failure, and to reduce cardiovascular risk in some patients. It works by lowering blood pressure and easing the heart’s workload. This is established pharmacology and relevant to interpreting safety notices.[8][9]
Recent safety and recall news (highlights)
- Several country/regulator recalls have occurred in 2024–2026 related to ramipril capsules where packaging or ingredient issues raised safety concerns. For example, in late 2024, a large recall in the U.S. involved ramipril products due to concerns about an ingredient sourced from an unapproved vendor, prompting the FDA to classify the risk level and issue recall notices. This reflects ongoing vigilance around manufacturing quality and supply chain integrity for ramipril products.[1]
- In the U.K., there have been multiple Class 2 recalls related to ramipril capsules from Crescent Pharma Limited, affecting certain batches and sometimes involving packaging errors where other tablets (e.g., amlodipine) were found in ramipril cartons. These are precautionary recalls with potential for medication errors but are not necessarily related to batch-wide potency failures; they require checking the specific batch numbers and expiry dates to identify affected lots.[2][3]
- As recently as May 2026, UK regulatory bodies and media outlets have reported urgent warnings about ramipril batches from Crescent Pharma, urging patients to verify batch numbers and expiry dates and to contact pharmacies if in doubt. The MHRA and related health information portals emphasize checking packaging and seeking medical advice if higher-strength capsules are involved or if adverse symptoms occur.[4][5]
- Official channels stress that if a mix-up happens and patients take a higher-strength ramipril dose, potential side effects can include lightheadedness, fainting, fatigue, or changes in kidney function, and medical evaluation is advised to assess risk and need for further testing.[5][4]
What to do if you’re taking ramipril
- Check the packaging for the batch number and strength. If you have a batch that is known to be affected, stop taking that batch and contact your pharmacist or doctor for alternatives or a replacement prescription.[3][4]
- If you have any symptoms such as dizziness, fainting, unusual fatigue, or changes in kidney function after taking ramipril, seek medical advice promptly. Report any suspected adverse reactions through your national pharmacovigilance system (e.g., Yellow Card scheme in the UK).[9][4]
- Do not stop ramipril abruptly without medical guidance, as sudden withdrawal can worsen cardiovascular risk; arrange a plan with your clinician if you need to switch or temporarily pause treatment due to a recall.[9]
Additional context
- Ramipril has well-established benefits for reducing cardiovascular events in appropriate patients, but manufacturing and packaging controls are critical for maintaining drug safety. This context explains why regulatory agencies issue recalls or warnings when procedural issues are detected in production or packaging.[8][9]
Illustration (example)
- If you’re checking a batch: look for the batch number GR164099 for the 5 mg Ramipril capsules recall in the UK (as part of Crescent Pharma Limited recall notices) and confirm expiry dates on the carton; if your carton differs, consult your pharmacy or prescriber.[2][3]
Citations
- Ramipril overview and uses: StatPearls, NIH (ramipril pharmacology).[8]
- U.S. recall due to unapproved vendor ingredient: Newsmax item on ramipril recall (2024).[1]
- U.K. Crescent Pharma ramipril recall details and batch issues: MHRA and related UK recall notices.[3][2]
- UK safety alerts and May 2026 warnings: GB News and LadBible reporting MHRA advisories.[4][5]
- UK pharmacovigilance and reporting adverse events: MHRA Yellow Card guidance (referenced in safety notices).[4]
If you’d like, I can tailor this to your location (Warsaw, Poland) and pull the latest local regulatory updates on ramipril safety and any country-specific recall notices. I can also help you verify your current batch against the recall lists and guide you on next steps with a checklist.